Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Product containing durapatite (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Product containing carboxymethylcellulose sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nutritional supplement |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carmellose sodium (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent pour l'appareil génito-urinaire |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Durapatite (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Product containing calcium hydroxyapatite |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Product containing carboxymethylcellulose sodium in parenteral dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Has manufactured dose form |
Parenteral dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Carmellose (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Is a |
Carmellose- and hydroxyapatite-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|